| Ferroptosis and cancer prognosis | Lifetime | 462 | CN 242 | 95.15 |
| Traditional Chinese Medicine Analysis | Lifetime | 251 | CN 201 | 96.35 |
| Circular RNAs in diseases | Lifetime | 742 | CN 405 | 95.97 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 554 | CN 54 | 95.73 |
| Plant-based Medicinal Research | Lifetime | 429 | CN 119 | 92.81 |
| Berberine and alkaloids research | Lifetime | 578 | CN 196 | 84.87 |
| Aldose Reductase and Taurine | Lifetime | 943 | CN 41 | 82.59 |
| Flavonoids in Medical Research | Lifetime | 722 | CN 308 | 77.82 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 825 | CN 544 | 70.93 |
| Immune cells in cancer | 2021-2025 | 97 | CN 57 | 97.60 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 26 | CN 23 | 96.71 |
| Epigenetics and DNA Methylation | 2021-2025 | 253 | CN 96 | 95.59 |
| Ferroptosis and cancer prognosis | 2021-2025 | 269 | CN 218 | 95.82 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 320 | CN 133 | 92.87 |
| Cancer-related molecular mechanisms research | 2021-2025 | 746 | CN 576 | 94.50 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 118 | CN 32 | 90.85 |
| Cancer-related Molecular Pathways | 2021-2025 | 323 | CN 56 | 86.21 |
| Circular RNAs in diseases | 2021-2025 | 849 | CN 607 | 86.63 |
| Cancer-related gene regulation | 2021-2025 | 700 | CN 469 | 80.70 |
| Allelopathy and phytotoxic interactions | 2021-2025 | 208 | CN 48 | 84.80 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 498 | CN 195 | 81.50 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 247 | CN 68 | 77.54 |
| Laser Material Processing Techniques | 2021-2025 | 752 | CN 410 | 81.15 |
| Sunflower and Safflower Cultivation | 2021-2025 | 125 | CN 26 | 73.76 |
| Fibroblast Growth Factor Research | 2021-2025 | 435 | CN 133 | 70.71 |
| Protein Tyrosine Phosphatases | 2021-2025 | 300 | CN 71 | 65.20 |
| Biological and pharmacological studies of plants | 2021-2025 | 325 | CN 264 | 62.29 |
| Medicinal Plants and Bioactive Compounds | 2021-2025 | 347 | CN 144 | 60.46 |
| Apelin-related biomedical research | 2021-2025 | 385 | CN 80 | 56.45 |
| Synthesis and Reactions of Organic Compounds | 2021-2025 | 367 | CN 71 | 51.93 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 955 | CN 153 | 48.32 |
